Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias01:22

Bias

3.7K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
3.7K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.2K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.2K
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

5.7K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
5.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

112
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
112
Randomized Experiments01:13

Randomized Experiments

6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

134
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Versus Prediction-Level Evaluation of a Dynamic Clinical Prediction Model of Sepsis.

Research square·2026
Same author

Effect of Using Personalized Estimates of Diabetes Risk During Primary Care Visits for People With Prediabetes.

Learning health systems·2026
Same author

Patient Versus Prediction-Level Evaluation of a Dynamic Clinical Prediction Model of Sepsis.

medRxiv : the preprint server for health sciences·2026
Same author

Mechanism Attribution After Cryptogenic Stroke: Toward a RoPE Score for Atrial Fibrillation Detected After Stroke.

Stroke·2026
Same author

Diagnostic Agreement and Prognostic Value of Clinically Interpreted CT vs MRI for Incidentally Discovered Covert Cerebrovascular Disease.

Neurology·2026
Same author

Patent Foramen Ovale Closure in Stroke and the PASCAL Classification System.

JAMA neurology·2026
Same journal

Predicting Chemotherapy Response from Staging Laparoscopy Images.

medRxiv : the preprint server for health sciences·2026
Same journal

Development and External Validation of a Machine Learning Model for 10-Year Ischemic Stroke Risk Prediction in Diverse Populations.

medRxiv : the preprint server for health sciences·2026
Same journal

MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative.

medRxiv : the preprint server for health sciences·2026
Same journal

Genetic and maternal environmental contributions to estimated fetal weight at 20 weeks gestation compared with birthweight.

medRxiv : the preprint server for health sciences·2026
Same journal

Better immediate declarative memory is associated with forgetting during locomotor adaptation in chronic stroke and in older adults.

medRxiv : the preprint server for health sciences·2026
Same journal

An empirical Bayes framework for burden and dispersion association tests helps prioritize rare variants associated with Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
See all related articles

Related Experiment Video

Updated: May 27, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Assessing Algorithm Fairness Requires Adjustment for Risk Distribution Differences: Re-Considering the Equal

Sarah E Hegarty1, Kristin A Linn1, Hong Zhang2

  • 1Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.

Medrxiv : the Preprint Server for Health Sciences
|February 20, 2025
PubMed
Summary
This summary is machine-generated.

Algorithm fairness metrics like equal opportunity can be misleading. A new metric, adjusted true positive rate (aTPR), ensures individuals with similar risks have equal opportunities for high-risk identification, regardless of subgroup.

Keywords:
Algorithm fairnessClinical decision-makingEqual opportunityHigh-risk identificationRisk distribution

More Related Videos

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.0K
Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.2K

Related Experiment Videos

Last Updated: May 27, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.0K
Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.2K

Area of Science:

  • Computer Science
  • Statistics
  • Healthcare Analytics

Background:

  • Algorithm-assisted decision-making necessitates robust fairness assessments.
  • Equal opportunity, a common fairness metric, relies on true positive rate (TPR) parity across subgroups.
  • Existing metrics may misinterpret performance disparities due to varying subgroup risk distributions.

Purpose of the Study:

  • To introduce a novel fairness metric, adjusted true positive rate (aTPR), addressing limitations of traditional TPR.
  • To ensure fairness evaluation accounts for differential risk distributions across population subgroups.
  • To promote equal treatment for individuals with similar underlying risks, irrespective of group affiliation.

Main Methods:

  • Developed aTPR metric by normalizing subgroup TPRs against a reference subgroup's risk distribution.
  • Conducted numerical experiments to analyze performance under various differential calibration scenarios.
  • Applied the aTPR metric to a real-world dataset predicting in-patient mortality risk.

Main Results:

  • Demonstrated that standard TPR can yield misleading fairness conclusions when risk distributions differ across subgroups.
  • Showcased how aTPR provides a more accurate assessment of fairness by adjusting for baseline risk variations.
  • Identified potential performance disparities in palliative care referral predictions using the aTPR metric.

Conclusions:

  • The adjusted true positive rate (aTPR) offers a more reliable approach to evaluating algorithmic fairness, especially when subgroup risk distributions vary.
  • Accurate fairness assessment is crucial for equitable deployment of algorithms in healthcare and other sensitive domains.
  • This work facilitates more equitable risk prediction and resource allocation, such as timely palliative care consultations.